Literature DB >> 17186223

Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking.

Undine E Lang1, Thomas Sander, Falk W Lohoff, Rainer Hellweg, Malek Bajbouj, Georg Winterer, Jürgen Gallinat.   

Abstract

RATIONALE: It has been suggested that a susceptibility locus near the gene encoding the brain-derived neurotrophic factor (BDNF) contributes to individual differences in human addiction vulnerability. BDNF modulates several behaviors that are associated with addictive drugs, and upregulation of BDNF was found to be associated with several drugs of abuse such as amphetamine, cocaine, and nicotine. In this study, we addressed the question if a common BDNF missense variation (Val66Met) influences the risk for smoking behavior in otherwise healthy human volunteers.
MATERIALS AND METHODS: In total, 320 healthy unrelated volunteers (155 male, 165 female, mean age: 38.4 +/- 14.1 years) consisting of 43.3% never smokers, 20.9% former smokers, and 35.6% current smokers were investigated.
RESULTS: The frequency of both Met/Met genotype and Met allele was significantly increased in current and in former smokers when compared to never smokers (chi (2) = 10.856, df = 2, p = 0.004 and chi (2) = 4.350, df = 1, p = 0.045, respectively).
CONCLUSIONS: Our results suggest that humans who carry the Met allele of the BDNF missense polymorphism might be more vulnerable to initiate and also maintain smoking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186223     DOI: 10.1007/s00213-006-0647-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  63 in total

1.  Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing.

Authors:  Jürgen Gallinat; Daniel Senkowski; Catrin Wernicke; Georg Juckel; Isabell Becker; Thomas Sander; Michael Smolka; Ulrich Hegerl; Hans Rommelspacher; Georg Winterer; Werner M Herrmann
Journal:  Neuropsychopharmacology       Date:  2002-07-25       Impact factor: 7.853

2.  Sensation seeking, puberty, and nicotine, alcohol, and marijuana use in adolescence.

Authors:  Catherine A Martin; Thomas H Kelly; Mary Kay Rayens; Bethanie R Brogli; Allen Brenzel; W Jackson Smith; Hatim A Omar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-12       Impact factor: 8.829

3.  Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing.

Authors:  J Gallinat; D Kunz; U E Lang; P Kalus; G Juckel; J Eggers; R Mahlberg; M Staedtgen; C Wernicke; H Rommelspacher; M N Smolka
Journal:  Pharmacopsychiatry       Date:  2005-07       Impact factor: 5.788

4.  Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons.

Authors:  L J Goodman; J Valverde; F Lim; M D Geschwind; H J Federoff; A I Geller; F Hefti
Journal:  Mol Cell Neurosci       Date:  1996-03       Impact factor: 4.314

5.  Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing.

Authors:  Undine E Lang; Rainer Hellweg; Jürgen Gallinat
Journal:  Neuropsychopharmacology       Date:  2005-06       Impact factor: 7.853

6.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects.

Authors:  J Gelernter; H Kranzler; J F Cubells
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

7.  A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

Authors:  Bernard Le Foll; Jorge Diaz; Pierre Sokoloff
Journal:  Neuroreport       Date:  2005-02-08       Impact factor: 1.837

Review 8.  The genetic epidemiology of smoking.

Authors:  P F Sullivan; K S Kendler
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

9.  The role of the serotonin transporter gene in cigarette smoking.

Authors:  C Lerman; P G Shields; J Audrain; D Main; B Cobb; N R Boyd; N Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-03       Impact factor: 4.254

10.  Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal.

Authors:  S Numan; S B Lane-Ladd; L Zhang; K H Lundgren; D S Russell; K B Seroogy; E J Nestler
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

View more
  37 in total

Review 1.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Genome-wide association study of smoking initiation and current smoking.

Authors:  Jacqueline M Vink; August B Smit; Eco J C de Geus; Patrick Sullivan; Gonneke Willemsen; Jouke-Jan Hottenga; Johannes H Smit; Witte J Hoogendijk; Frans G Zitman; Leena Peltonen; Jaakko Kaprio; Nancy L Pedersen; Patrik K Magnusson; Tim D Spector; Kirsten Ohm Kyvik; Katherine I Morley; Andrew C Heath; Nicholas G Martin; Rudi G J Westendorp; P Eline Slagboom; Henning Tiemeier; Albert Hofman; Andre G Uitterlinden; Yurii S Aulchenko; Najaf Amin; Cornelia van Duijn; Brenda W Penninx; Dorret I Boomsma
Journal:  Am J Hum Genet       Date:  2009-03-05       Impact factor: 11.025

Review 3.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

4.  Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs.

Authors:  M Falcone; C Jepson; P Sanborn; J N Cappella; C Lerman; A A Strasser
Journal:  Genes Brain Behav       Date:  2011-10-06       Impact factor: 3.449

5.  Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats.

Authors:  Fábio Teixeira Kuhn; Verônica Tironi Dias; Karine Roversi; Luciana Taschetto Vey; Daniele Leão de Freitas; Camila Simonetti Pase; Katiane Roversi; Juliana Cristina Veit; Tatiana Emanuelli; Marilise Escobar Bürger
Journal:  Neurotox Res       Date:  2015-07-19       Impact factor: 3.911

6.  Biological underpinnings of an internalizing pathway to alcohol, cigarette, and marijuana use.

Authors:  Elisa M Trucco; Sandra Villafuerte; Andrea Hussong; Margit Burmeister; Robert A Zucker
Journal:  J Abnorm Psychol       Date:  2017-11-27

7.  Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.

Authors:  Bridgin G Lee; Agustin Anastasia; Barbara L Hempstead; Francis S Lee; Julie A Blendy
Journal:  Nicotine Tob Res       Date:  2015-03-05       Impact factor: 4.244

8.  Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.

Authors:  Emilia Romano; Andrea Fuso; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

9.  What keeps a body moving? The brain-derived neurotrophic factor val66met polymorphism and intrinsic motivation to exercise in humans.

Authors:  Ann E Caldwell Hooper; Angela D Bryan; Martin S Hagger
Journal:  J Behav Med       Date:  2014-05-08

10.  Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism.

Authors:  Cherubino Di Lorenzo; Giorgio Di Lorenzo; Grazia Sances; Natascia Ghiotto; Elena Guaschino; Gaetano S Grieco; Filippo M Santorelli; Carlo Casali; Alfonso Troisi; Alberto Siracusano; Francesco Pierelli
Journal:  J Headache Pain       Date:  2009-06-11       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.